Merck has opened a new Launch and Technology Center for healthcare in Darmstadt, costing the company around €160 million. This is part of a planned investment of more than €1.5 billion at the global headquarters in Darmstadt by 2025. The Launch and Technology Center will bridge research and commercial production… Read More
Using deadly spider venom to treat heart attacks is one of many new discoveries currently being developed at a national research centre headquartered at The University of Queensland. The Australian Research Council (ARC) Centre of Excellence for Innovations in Peptide and Protein Science (CIPPS) was launched this week at its… Read More
DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients. For patients participating in a clinical trial, the experience can be one of considerable hardship, both from a perspective on their health and the impact… Read More
DDW’s Megan Thomas looks at three regions and their approach to digitalisation. 1. United Kingdom A report published by the Association of the British Pharmaceutical Industry (ABPI) has identified the skills and training conditions needed for the future success of UK life sciences. George… Read More
China-based Sinocompound Catalysts has partnered with InCatT to launch a specialist Catalyst Screening Service for pharmaceutical and fine chemical companies looking to optimise their reactions. The service The new service draws on InCatT’s experience in screening homogeneous catalysts combined with Sinocompound’s expertise in custom synthesis, scale-up and manufacturing of advanced catalysts and ligands. By combining… Read More
The Chief Executive of the UK’s Association of the British Pharmaceutical Industry (ABPI), Richard Torbett, has stressed the importance of investment in research in response to the Queen’s Speech delivery. “The response to the pandemic has shown just how critical the UK’s pharmaceutical industry is to our country’s future and… Read More
Biotechnology company PerkinElmer has announced its documentation, workflow and decision-making informatics platform, Signals, is expanding to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With the collaboration, pharmaceutical and academic research… Read More
